Tag: Lilly

US grants emergency approval to Lilly Covid-19 antibodies

  WASHINGTON, United (AFP) — The US Food and Drug Administration on Monday granted emergency approval to a synthetic antibody treatment against Covid-19 developed by Eli Lilly, after the drug was shown to reduce the risk of hospitalization and emergency room visits. Bamlanivimab at a dose of 700 milligrams was authorized for the treatment of mild-to-moderate Covid-19 in adults and children aged 12 years and older who are at high risk for progressing to the […]

Second Covid-19 trial paused within 24 hours over safety concerns

WASHINGTON, United States (AFP) — Two late-stage Covid-19 medical trials have been paused in the space of 24 hours over potential safety concerns, the latest setbacks to scientists in the long fight against the pandemic. US pharmaceutical firm Eli Lilly on Tuesday suspended its Phase 3 trial of its lab-produced antibody treatment in hospitalized patients over an unspecified incident. A day earlier, the American pharmaceutical giant Johnson & Johnson temporarily halted its Phase 3 Covid-19 […]